Janssen, J., Löwenberg, B., Manz, M., Bargetzi, M., Biemond, B., Borne, P. v. d., . . . Ossenkoppele, G. (2021). Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS. Cancers (Basel).
Citação norma ChicagoJanssen, Jeroen, et al. "Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients With AML and High Risk MDS." Cancers (Basel) 2021.
Citação norma MLAJanssen, Jeroen, et al. "Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients With AML and High Risk MDS." Cancers (Basel) 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.